📖 A new comprehensive protocol for recurrent paroxysmal atrial fibrillation (PAF) ablation resulted in arrhythmia-free survival at 1-year in 53% of patients. None of the ablation protocol’s steps were suggested to independently improve procedural success ⬇️
https://t.co/4TNlVmx2mN
#CJC
Sharing what we hope is an important paper in #SHOCK out today in @NEJMEvidence by @JungRichardG (who just matched to cardiology!).
Prognostic Factors Associated with Mortality in Cardiogenic Shock — A Systematic Review and Meta-Analysis | NEJM Evidence https://t.co/Qm5v2D1Wne
We clearly need more dedicated #CICU trials of #VTstorm to learn how to treat these patients. It's like early days of cardiogenic shock.
With @fdanielramirez we are doing the SEDATE trial looking at Precedex up front for treatment of VT storm and have started recruiting.
How can we improve #POCUS utility and democratize application - #AI augmentation! Both senior and novice scanners can rapidly and accurately measure and classify LVEF across clinical settings (echo lab, ward, ED, ICU).
🚨New #FreeRead Article in
@JICE_EP
Optimized Workflow for PVI using 90-W Radiofrequency Applications: a Comparative Study
by @AgustinBortone@fdanielramirez S Combes, G Laborie, JP Albenque, FA Sebag & LR Limite
🧐📖 https://t.co/G9fDPrRrx6
#EPeeps
Clinically relevant arrhythmic events occur in approximately half of patients with #CardiogenicShock treated with dobutamine or milrinone and are associated with adverse clinical outcomes #cardiotwitter#CJC 👉 https://t.co/7M00bYyTXR
Can #smartwatch#ECG be used in children? #epeeps from @ihu_liryc@CHUBordeaux show how @Apple ⌚️ ECGs recorded with parental assistance (<6y 👩👦) and independently (>6y🧒) can detect🫀conditions. In Journal of Pediatrics with temporary free access here: https://t.co/WbFhjg4nGx
Newest DOREMI substudy from @benhibbertMDPhD's lab in @CJCJournals 🚨 - led by @fdanielramirez where we reveal 48% in those with cardiogenic shock had arrhythmic events while on inotropes with increased odds of mortality. #Cardio
https://t.co/4FtzR4AiEG
Our latest from the @benhibbertMDPhD lab, published in @Open_HeartBMJ.
AF is highly predictive of adverse outcomes following coronary revascularization. AF is a stronger predictor of MACE than traditional risk factors ie T2DM/reduced LVEF in this study.
https://t.co/Czc1LEpZQt
Latest publication alert 🚨 from @benhibbertMDPhD's lab at @JACCJournals - we demonstrate that PAI-1 extracellular vesicles are biomarkers for MACE in CAD. Also, PAI-1 EV modulates the proinflammatory vascular SMC phenotype opening a target for ISR. https://t.co/mWwy2Xx5JA
Noncontact whole-chamber charge density mapping of the left ventricle: Preclinical evaluation in a sheep model, by @fdanielramirez@JRWinterfield@PierreJais et al https://t.co/v9PZojLVGS
Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients with Heart Failure and Atrial Fibrillation: results from the RAFT-AF trial https://t.co/6USscnP9Vi @AnthonyTang6 @EPjeff17@CHRS_SCR@CANetChat